6.77 M
About Adhera Therapeutics Inc.
Adhera Therapeutics, Inc. is an emerging specialty biotech company, which is in the process of evaluating its focus including a return to drug discovery and development. The company was founded on September 23, 1983 and is headquartered in Baton Rouge, LA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ATRX is 0.0024 USD — it has increased by 1.10 K% in the past 24 hours. Watch Adhera Therapeutics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Adhera Therapeutics Inc. stocks are traded under the ticker ATRX.
ATRX reached its all-time high on Jan 27, 1986 with the price of 1,800,000.0000 USD, and its all-time low was 0.0001 USD and was reached on Sep 6, 2024. View more price dynamics on ATRX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ATRX stock is 91.67% volatile and has beta coefficient of −17.58. Track Adhera Therapeutics Inc. stock price on the chart and check out the list of the most volatile stocks — is Adhera Therapeutics Inc. there?
Yes, you can track Adhera Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
No, ATRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ATRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Adhera Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Adhera Therapeutics Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Adhera Therapeutics Inc. stock shows the sell signal. See more of Adhera Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.